Perrigo, INC.
Develop, manufacture, and distribute packaging of OTC & prescription pharmaceuticals.
Based in MI
AI Overview
With $300K in lobbying spend across 14 quarterly filings, Perrigo, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $60K |
| 2020 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Perrigo, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Pharmacy
Monitor issues as they relate to the implementation of tax reform.
Dextromethorphan, Pseudoephedrine restriction issues.
Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicine
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.